← Leaderboards
Ronald T Aimes
Mapp Biopharmaceutical, Inc.
$3,000,000
Attributed
$3,000,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2017–19$1M$750K$500K$250K$0
'17
'18
'19
Funding mix
By agency
NIH$3,000,000 · 1
By mechanism
SB1$3,000,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Mapp Biopharmaceutical, Inc.
Same institution · by research overlap
- Adrian Guthals$1,345,419
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteDisease OutbreaksAerosolsAnimalsAfricaDangerousnessAnimal ModelBaseBindingBiological ProductsAnthrax DiseaseBioreactorsBioterrorismAntibodiesCategoriesCell BankCell LineCellsCenters For Disease Control And Prevention (U.S.)Chinese Hamster Ovary CellClinical ResearchCollaborationsCross ReactivityDose